Vanguard Group Inc Passage Bio, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PASG
# of Institutions
44Shares Held
32.7MCall Options Held
8.3KPut Options Held
400-
Orbimed Advisors LLC San Diego, CA10.1MShares$6.68 Million0.19% of portfolio
-
Vestal Point Capital, LP New York, NY6.05MShares$3.99 Million0.36% of portfolio
-
Versant Venture Management, LLC San Francisco, CA4.03MShares$2.66 Million7.06% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$1.65 Million2.4% of portfolio
-
Tang Capital Management LLC San Diego, CA1.5MShares$990,0000.14% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $35.9M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...